HTA322 Modelling Antifibrotic Therapies for Idiopathic Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Disease: Learnings from NICE Submissions from the Past Decade
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2005
https://www.valueinhealthjournal.com/article/S1098-3015(23)05135-5/fulltext
Title :
HTA322 Modelling Antifibrotic Therapies for Idiopathic Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Disease: Learnings from NICE Submissions from the Past Decade
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05135-5&doi=10.1016/j.jval.2023.09.2005
First page :
Section Title :
Open access? :
No
Section Order :
11451